Frequent hypermethylation of the 5′ CpG island of E-cadherin in esophageal adenocarcinoma

Clinical Cancer Research

Volumn 7, Issue 9, 2001, Pages 2765-2769

  Corn, Paul G ^a   Fogt, Franz ^a   Heath, Elisabeth I ^b   Heitmiller, Richard ^b   Forastiere, Arlene A ^b   Herman, James G ^b   Wu, Tsung Teh ^c  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; UVOMORULIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS MUCOSA; FEMALE; GENE MUTATION; HOMEOSTASIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; METHYLATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CADHERINS; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; TUMOR CELLS, CULTURED;

EID: 0034813946     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Morphogenetic roles of classic cadherins
2. E-cadherin-catenin: More than a "sticky" molecular complex
3. E-cadherin expression in renal cell cancer and its significance in metastasis and survival
4. Separating favorable from unfavorable prognostic markers in breast cancer: The role of E-cadherin
5. Reduced E-cadherin expression is associated with increased lymph node metastasis and unfavorable prognosis in non-small cell lung cancer
6. Down-regulation and abnormal expression of E-cadherin and β-catenin in nasopharyngeal carcinoma: Close association with advanced disease stage and lymph node metastasis
7. Prognostic value of the expression of E-cadherin and β-catenin in bladder cancer
8. An immunohistochemical study of E-cadherin expression with correlations to clinicopathological features in gastric cancer
9. Decreased E-cadherin expression is associated with hematogenous recurrence and poor prognosis in patients with squamous cell carcinoma of the esophagus
10. E-cadherin germline mutations in familial gastric cancer
11. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer
12. Mutations of the human E-cadherin (CDH1) gene
13. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas
14. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma
15. MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas
16. The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas
17. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas
18. Reduced expression of E-cadherin in oral squamous cell carcinoma: Relationship with DNA methylation of 5′ CpG island
19. E-cadherin gene promoter hypermethylation in primary human gastric carcinomas
20. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
21. Adenocarcinoma of the esophagus and gastric cardia: Is there progress in the face of increasing cancer incidence?
22. Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus
23. Evolution of neoplastic cell lineages in Barrett's esophagus
24. The molecular pathology of Barrett's esophagus
25. Genetic alterations in Barrett's esophagus and adenocarcinomas of the esophagus and esophagogastric junction region
26. Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus
27. Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence: Correlation with disease progression and dedifterentiation
28. Reduced expression of the cadherin-catenin complex in esophageal adenocarcinoma correlates with poor prognosis
29. E-cadherin gene mutations are rare in adenocarcinomas of the esophagus
30. Genetic divergence in the clonal evolution of breast cancer
31. E-cadherin expression is silenced by 5′ CpG island methylation in acute leukemia
32. Methylation-specific PCR: A novel assay for methylation status of CpG islands
33. E-cadherin and a-catenin expression in human esophageal cancer
34. Inhibition of β-catenin-mediated transactivation by cadherin derivatives
35. Functional interaction of β-catenin with the transcription factor LEF-1
36. DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci
37. Distinct patterns of E-cadherin CpG island methylation in papillary, follicular, Hurthle's cell, and poorly differentiated human thyroid carcinoma
38. Epigenetic patterns in the progression of esophageal adenocarcinoma